Article
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
13 Jul 2010
Abstract excerpt
Glioblastoma (GBM) is the most aggressive primary brain tumor and is resistant to all therapeutic regimens. Relapse occurs regularly and might be caused by a poorly characterized tumor stem cell (TSC) subpopulation escaping therapy. We suggest aldehyde dehydrogenase 1 (ALDH1) as a novel stem cell marker in human GBM. Using the neurosphere formation assay as a functional method to identify brain TSCs, we show that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
